Decentralized Clinical Trials. What does the future hold?

Over the last two years, the COVID-19 pandemic has caused a shift of dynamics towards decentralized clinical trials, rapidly accelerating the trend. Lockdowns, the redevelopment of medical facilities for COVID-19 treatment, and shortages of medical professionals, have complicated the manner in which traditional, fully centralized clinical trials are conducted. You could call the pandemic a

Patients’ Portal: New Languages added

As part of our ongoing commitment to ensuring our patients are well informed about their role in the clinical trials process, Cromos Pharma has translated its patient portal into multiple new languages. In addition to currently available languages that include English, Czech, Georgian, Hungarian, Polish, Ukrainian, Russian, we have added information in Romanian, Slovak, Bulgarian, Türkiyesh,

Key Takeaways from the BIO International Convention 2022
Key Takeaways from the BIO International Convention 2022

Nicole Brenna, US Business Development Director, represented Cromos Pharma at the BIO International Convention. Please read her key takeaways from the event. “This was my first BIO conference in person and it was great meeting Sponsors and our partners from all over the world. It was definitely nice to finally shake hands and exchange business cards,